Stock BIOVIC B BIOVICA INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Biovica International AB

Equities

BIOVIC B

SE0008613731

Delayed Nasdaq Stockholm
Other stock markets
 03:12:55 2024-05-13 am EDT 		5-day change 1st Jan Change
1.62 SEK -0.61% Intraday chart for Biovica International AB -1.82% -37.21%
Apr. 13 Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. CI
Apr. 12 Biovica International AB Announces Divitum® Tka in Observational Trial CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biovica saves SEK 30 million year and investigates new go-to market model in US
AQ
Biovica saves SEK 30 million/year and investigates new go-to market model in US
AQ
Biovica - DiviTum TKa in observational trial
AQ
DiviTum TKa in Observational Trial
AQ
Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024.
CI
DiviTum® TKa in observational trial
AQ
Biovica International AB Announces Divitum® Tka in Observational Trial
CI
Biovica International AB Announces Appointments to the Nomination Committee
CI
Nomination Committee for Biovica International AB for the 2024 Annual General Meeting
AQ
Biovica receives positive patent notification for immunotherapies
AQ
Biovica - Commercial progress despite a quarter with modest sales
AQ
Transcript : Biovica International AB, Q3 2024 Earnings Call, Mar 14, 2024
Q3 Interim Report November-January 2023/2024
AQ
Biovica International AB Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
Interventional DiviTum® TKa trial launches at Washington University
AQ
Biovica Announces Interventional DiviTum TKa Trial Launches at Washington University
CI
Biovica International Signs SEK 1.2 Million Master Service Agreement
CI
Biovica signs master service agreement
AQ
Biovica Signs Master Service Agreement for Tka Testing with Leading Pharma Company
CI
Biovica signs master service agreement for TKa testing with leading pharma company
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOVIC B Stock
  4. News Biovica International AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW